Oncology

Oncology

ViewtheOncologypageforhealthcareprofessionalsandfindmoreinformationonAlimta(pemetrexedforinjection),Cyramza(ramucirumab)injection, ...。其他文章還包含有:「AKTISONCOLOGYENTERSINTOSTRATEGIC...」、「AktistocollaboratewithEliLillyoncancertherapies」、「CancerMedicationsandSupportPrograms」、「EliLillyAcquiringCancerTherapyDeveloperFor$1.4...」、「EliLillyandAktisOncologyPartnertoAdvanceNovel...」...

查看更多 離開網站

eli lilly疫苗Eli Lilly coeli lilly減肥藥eli lilly減肥eli lilly胰島素eli lilly中文Eli Lilly
Provide From Google
AKTIS ONCOLOGY ENTERS INTO STRATEGIC ...
AKTIS ONCOLOGY ENTERS INTO STRATEGIC ...

https://www.aktisoncology.com

AKTIS ONCOLOGY ENTERS INTO STRATEGIC COLLABORATION WITH LILLY TO DISCOVER AND DEVELOP NOVEL ANTICANCER RADIOPHARMACEUTICALS.

Provide From Google
Aktis to collaborate with Eli Lilly on cancer therapies
Aktis to collaborate with Eli Lilly on cancer therapies

https://www.reuters.com

Aktis Oncology said on Tuesday it will collaborate with Eli Lilly (LLY.N) to develop cancer therapies, making it eligible for milestone payments of up to $1.1 ...

Provide From Google
Cancer Medications and Support Programs
Cancer Medications and Support Programs

https://www.lilly.com

Lilly is dedicated to developing innovative new cancer medicines. Learn about those now available and in the oncology pipeline.

Provide From Google
Eli Lilly Acquiring Cancer Therapy Developer For $1.4 ...
Eli Lilly Acquiring Cancer Therapy Developer For $1.4 ...

https://www.forbes.com

Eli Lilly broadened its cancer research efforts in 2019 when it purchased Loxo Oncology for $8 billion. At the time, Eli Lilly CEO David Ricks ...

Provide From Google
Eli Lilly and Aktis Oncology Partner to Advance Novel ...
Eli Lilly and Aktis Oncology Partner to Advance Novel ...

https://www.geneonline.com

Eli Lilly announces a drug discovery collaboration with Aktis Oncology, a biotech company developing radiopharmaceuticals for solid tumors.

Provide From Google
Lilly Inks Potential $1.1B Radiopharma Deal with Aktis ...
Lilly Inks Potential $1.1B Radiopharma Deal with Aktis ...

https://www.biospace.com

Eli Lilly is paying $60 million upfront to Aktis Oncology to discover and develop novel tumor-targeting radiopharmaceuticals.

Provide From Google
Lilly Oncology Pipeline
Lilly Oncology Pipeline

https://www.lillyoncologypipel

Review Lilly's oncology pipeline to see the current clinical trials for cancer patients, and to see whether or not we are accepting enrollments.

Provide From Google
Lilly Oncology Pipeline Database
Lilly Oncology Pipeline Database

https://www.lillyoncologypipel

Explore our oncology pipeline database, discover promising therapies in development for diverse unmet medical needs, and download HCP resources.